相关实验视频
Updated: Jun 22, 2025

11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
22.4K
帕金森病中的深度大脑刺激机制:即时和长期影响
Honglong Pei1, Zhenghan Wu1, Li Ma1
1Second Department of Neurosurgery, First Affiliated Hospital of Kunming Medical University, 650032 Kunming, Yunnan, China.
Journal of integrative neuroscience
|June 28, 2024
概括
深度大脑刺激 (DBS) 通过影响电气和神经化学通路来提供帕金森病 (PD) 管理. 本综述详细介绍了DBS机制,临床用途以及PD治疗的当前研究.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
- 生物医学工程 生物医学工程
背景情况:
- 深度大脑刺激 (DBS) 是帕金森病 (PD) 的广泛采用的临床治疗方法.
- 尽管它是有效的,但DBS治疗效果背后的精确机制仍然不完全理解.
- 目前的理解表明,其中涉及电气和神经化学调制.
研究的目的:
- 为帕金森病中DBS的基本概念提供全面的综述.
- 探索DBS发挥治疗效果的各种作用机制.
- 讨论PD管理中的DBS的临床影响和最近的进展.
主要方法:
- 对帕金森病的DBS现有研究的文献综述.
- 对调查DBS电气和神经化学效应的研究进行分析.
- 综合临床试验数据和最近的研究发现.
主要成果:
- 通过电刺激,DBS调节神经活动,影响向和非向的大脑区域.
- 神经化学变化,包括神经递质释放的改变 (例如多巴胺,GABA),有助于DBS的疗效.
- 新出现的证据表明,额外的机制,如质细胞调节和网络重置,发挥作用.
结论:
- DBS是一种多方面的帕金森病治疗方法,通过电气,神经化学和潜在的其他生物途径的组合起作用.
- 对这些机制的更深入的理解可以优化当前的DBS协议并指导未来的治疗策略.
- 持续的研究对于完善DBS应用和改善帕金森病患者的治疗结果至关重要.
更多相关视频
相关概念视频
Parkinson's Disease: Treatment
254
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
254
Parkinson's Disease: Overview
523
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
523

